10.1007/s40204-017-0072-z

Formulation, physicochemical characterization and in vitro evaluation of human insulin-loaded microspheres as potential oral carrier

HTML PDF
  • Gauravkumar R. Agrawal*1,
  • Pravin Wakte1,
  • Santosh Shelke2,
  1. Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, 431004, IN
  2. Department of Pharmaceutics, Yash Institute of Pharmacy, Aurangabad, Maharashtra, 431134, IN
Cover Image

Published in Issue 2017-09-01

How to Cite

Agrawal, G. R., Wakte, P., & Shelke, S. (2017). Formulation, physicochemical characterization and in vitro evaluation of human insulin-loaded microspheres as potential oral carrier. Progress in Biomaterials, 6(3 (September 2017). https://doi.org/10.1007/s40204-017-0072-z
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Abstract The objective of the present investigation was to formulate and characterize the human insulin entrapped Eudragit S100 microspheres containing protease inhibitors and to develop an optimized formulation with desirable features. A w/o/w multiple emulsion solvent evaporation technique was employed to produce microspheres of human insulin using Eudragit S-100 as coating material and polyvinyl alcohol as a stabilizer. The resultant microspheres were evaluated for drug-excipient compatibility, encapsulation efficiency, particle size, surface morphology, micromeritic properties, enteric nature, and in vitro drug release studies. Micromeritic properties indicated good flow properties and compressibility. In present investigation formulation F6 with drug/polymer ratio (1:100) was found to be optimal in terms of evaluated parameters where it showed a significantly higher percentage of encapsulation efficiency (76.84%) with minimal drug release (3.25%) in an acidic environment. The optimized formulation (F6) also possessed good spherical shape and particle size (57.42 µm) required to achieve the desired in vitro drug release profile at pH 7.4. The results confirmed that human insulin-loaded Eudragit S-100 microspheres containing protease inhibitor possessed good encapsulation efficiency, pH dependant controlled release carrying encapsulated insulin to its optimum site of absorption. This ultimately resulted in enhanced insulin absorption and biological response. Graphical Abstract

Keywords

  • W/O/W multiple emulsion,
  • Eudragit S-100,
  • Microspheres,
  • Controlled release,
  • Oral insulin,
  • Protease inhibitors
HTML PDF

References

  1. Adameova and Dhalla (2014) Role of microangiopathy in diabetic cardiomyopathy (pp. 25-33) https://doi.org/10.1007/s10741-013-9378-7
  2. Al-Remawi et al. (2017) Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system (pp. 390-398) https://doi.org/10.1080/10837450.2016.1213745
  3. Asani et al. (2016) In vitro studies on the pleiotropic antidiabetic effects of zinc oxide nanoparticles (pp. 1671-1687) https://doi.org/10.2217/nnm-2016-0119
  4. Ashford M (2017) Gastrointestinal tract–physiology and drug absorption. Aulton’s pharmaceutics e-book: the design and manufacture of medicines. pp 300
  5. Babu et al. (2008) Developments in polymeric devices for oral insulin delivery (pp. 403-415) https://doi.org/10.1517/17425247.5.4.403
  6. Becker et al. (2014) Novel orally swallowable IntelliCap® device to quantify regional drug absorption in human GI tract using diltiazem as model drug (pp. 1490-1497) https://doi.org/10.1208/s12249-014-0172-1
  7. Bloch et al. (2017) Insulin delivery to the brain using intracranial implantation of alginate-encapsulated pancreatic islets https://doi.org/10.1002/term.2235
  8. Cefalu (2004) Concept, strategies, and feasibility of noninvasive insulin delivery (pp. 239-246) https://doi.org/10.2337/diacare.27.1.239
  9. Das et al. (2015) Formulation development and statistical optimization of ibuprofen-loaded polymethacrylate microspheres using response surface methodology (pp. 1-14) https://doi.org/10.1016/j.cherd.2015.01.014
  10. De Rosa et al. (2000) Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres (pp. 283-295) https://doi.org/10.1016/S0168-3659(00)00315-1
  11. du Plessis et al. (2010) Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride (pp. 399-407) https://doi.org/10.3109/10717541003762888
  12. Freiberg and Zhu (2004) Polymer microspheres for controlled drug release (pp. 1-18) https://doi.org/10.1016/j.ijpharm.2004.04.013
  13. George and Abraham (2006) Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review (pp. 1-14) https://doi.org/10.1016/j.jconrel.2006.04.017
  14. Goldberg and Gomez-Orellana (2003) Challenges for the oral delivery of macromolecules (pp. 289-295) https://doi.org/10.1038/nrd1067
  15. Hostrup S, Huus K, Parshad H (2009) Modification of peptides and proteins. Delivery technologies for biopharmaceuticals: peptides, proteins, nucleic acids and vaccines. pp 171
  16. Ibrahim et al. (2005) Stability of insulin during the erosion of poly (lactic acid) and poly (lactic-co-glycolic acid) microspheres (pp. 241-252) https://doi.org/10.1016/j.jconrel.2005.02.025
  17. Jain et al. (2005) Eudragit S100 entrapped insulin microspheres for oral delivery 6(1) (pp. E100-E107) https://doi.org/10.1208/pt060116
  18. Khafagy et al. (2007) Current challenges in non-invasive insulin delivery systems: a comparative review (pp. 1521-1546) https://doi.org/10.1016/j.addr.2007.08.019
  19. Kumria and Goomber (2011) Emerging trends in insulin delivery: buccal route (pp. 1-9) https://doi.org/10.1007/s13340-011-0020-4
  20. Lee et al. (2002) Review on the systemic delivery of insulin via the ocular route (pp. 1-18) https://doi.org/10.1016/S0378-5173(01)00920-6
  21. Leeladurga et al. (2016) Application of microneedle arrays for enhancement of transdermal permeation of insulin: in vitro experiments, scaling analyses and numerical simulations (pp. 915-922) https://doi.org/10.1208/s12249-015-0416-8
  22. Maroni et al. (2016) In-vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin (pp. 76-82) https://doi.org/10.1016/j.ejpb.2016.08.002
  23. Morishita and Park (2009) CRC Press
  24. Muheem et al. (2016) A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives (pp. 413-428) https://doi.org/10.1016/j.jsps.2014.06.004
  25. Owens (2002) New horizons—alternative routes for insulin therapy (pp. 529-540) https://doi.org/10.1038/nrd836
  26. Pettit and Gombotz (1998) The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals (pp. 343-349) https://doi.org/10.1016/S0167-7799(98)01186-X
  27. Pfützner and Forst (2005) Pulmonary insulin delivery by means of the Technosphere™ drug carrier mechanism (pp. 1097-1106) https://doi.org/10.1517/17425247.2.6.1097
  28. Sajeesh and Sharma (2004) Poly methacrylic acid-alginate semi-IPN microparticles for oral delivery of insulin: a preliminary investigation (pp. 35-45) https://doi.org/10.1177/0885328204042992
  29. Shargel et al. (2004) Applied biopharmaceutics and pharmacokinetics
  30. Shelke et al. (2015) Formulation and evaluation of thermoreversible mucoadhesive in situ gel for intranasal delivery of naratriptan hydrochloride (pp. 238-244) https://doi.org/10.1016/j.jddst.2015.08.003
  31. Shelke et al. (2016) Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide (pp. 1-3) https://doi.org/10.1007/s10856-016-5713-6
  32. Soni (2017) Novel formulation strategies for insulin delivery (pp. 119-127)
  33. Torosantucci et al. (2014) Development of a transgenic mouse model to study the immunogenicity of recombinant human insulin (pp. 1367-1374) https://doi.org/10.1002/jps.23935
  34. Trivedi et al. (2014) Preparation and characterization of aceclofenac microspheres https://doi.org/10.22377/ajp.v2i2.186
  35. Yuan et al. (2009) Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion (pp. 212-218) https://doi.org/10.1016/j.ejps.2008.08.009